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It has recently been demonstrated in this laboratory (1) that the composite mixture 
of the  isolated  alternative  pathway  proteins  (C3,  factor  B,  factor  D,  fllH,  C3b 
inactivator, and properdin) and the isolated membrane attack pathway proteins (C5, 
C6, C7, C8, and C9) constitutes an intact cytolytic alternative pathway quantitatively 
comparable to that of human serum. In these studies, mammalian cells were used as 
activating  target  cells.  Because  of apparent  implications  for our understanding  of 
nonspecific resistance  to  infections, we  tested  the  isolated  component  system  with 
respect  to its ability to eradicate gram-negative bacteria. Using Escherichia  coli  K12 
W1485 we found that the 11 component system was capable of killing the bacteria in 
the total absence of immunoglobulins or other serum factors. Killing was associated 
with  distinct  morphological  changes  of the  bacteria,  but  not  with  disintegration. 
Disintegration or lysis required, in addition to the  11 proteins, lysozyme. 
Information regarding the bactericidal activity of the alternative pathway is scarce. 
That the proteins of the alternative pathway can be involved in bactericidal reactions 
against  certain bacterial strains has been demonstrated through the use of factor B- 
depleted human serum  (2)  and C4-deficient guinea pig serum  (3).  Whether specific 
antibody  is  required  or  not  has  remained  uncertain  (4-11).  The  requirement  of 
lysozyme for complement-dependent lysis of gram-negative bacteria  has  been  well 
documented (12,  13). However, all requirements of accessory factors and of late acting 
complement components known to date have been elaborated by studying bacteriol- 
ysis via the classical pathway and serum reagents rather than isolated proteins. 
Materials and Methods 
Buffers.  VB: veronal-buffered physiological saline, pH  7.4; VB++: VB containing 0.15 mM 
CaCl2 and 0.5 mM MgClz; HBS:  Hank's balanced salt solution; and GHBS: I HBS containing 
0.1% gelatin. 
Purified Components.  C3  (14),  factor  B  (2),  factor  D  (15),  C3b  inactivator  (16), fllH  (16), 
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native  properdin  (17),  C5  (14),  C6  (18),  C7  (18),  C8  (19),  and  C9  (20)  were  prepared  as 
described.  Purity of the  isolated proteins was  assessed, in  part,  by  sodium  dodecyl sulfate- 
polyacrylamide gel electrophoresis. Representative gel patterns have been published previously 
(1).  In  this study, at  least  two different  preparations of each  protein were used.  Egg white 
lysozyme [three times recrystallized] was purchased from Sigma Chemical Co. (St. Louis, Mo.). 
Human  lysozyme was  purchased  from  Worthington  Biochemical  Corp.  (Freehold,  N.  J.). 
Proteins were radioiodinated using the lactoperoxidase method of David and Reisfeld (21). 
Preparation of the Isolated Component Mixture.  The  mixture of purified components at  their 
physiological concentrations was prepared as described (1). Possible C3b contamination of C3 
preparations was eliminated by incubation of C3 with appropriate amounts of fllH and C3b 
inactivator just  before  the  addition  of the  other  eight  isolated  proteins.  Final  component 
concentrations were:  1,200 p,g/ml C3, 200 #g/ml factor B, 2/~g/ml factor D, 470 #g/ml fllH, 
34/~g/ml C3b  inactivator, 20 #g/ml native properdin, 72 pg/ml C5, 64/~g/ml C6, 54/~g/ml 
C7, 54/~g/ml C8, and 58/~g/ml C9. Before use in the bactericidal assays, the isolated component 
mixture was tested for the ability to lyse rabbit erythrocytes as described previously (1)  and 
compared with C4-depleted serum. 
C4-Depleted Human Serum.  Normal human serum was immunochemically depleted of C4 by 
utilizing a  Sepharose 4B  column  (Pharmacia  Fine Chemicals, Div.  of Pharmacia  Inc.,  Pis- 
caraway, N. J.)  to which the IgG fraction of monospecific anti-human  C4 serum  had  been 
coupled (22). 
Bacteria.  E. coli K12 W1485 were kindly supplied to us in a  lyophilized state by Dr. John 
Spizizen (Research Institute of Scripps Clinic). Organisms were cultured and maintained on 
1.3% agar slants containing  1.0% Difco protease peptone No.  3  (Difco Laboratories, Detroit, 
Mich.), 0.1%  Difco bacto beef extract  (Difco Laboratories), and  0.5%  NaC1.  Broth  cultures 
were established by transferring 25/~1 of slant culture to 5 ml of 3% trypticase soy broth (TSB) 
(BBL Microbiology Systems, Becton, Dickinson & Co., Cockeysville, Md.) and by incubation 
for 18 h at 37°C. 
asP-Labeling ofE. coli.  The medium used for labeling was a Tris buffered, minimal phosphate 
medium, pH 7.4, containing per liter the following materials: 0.022 g K2HPO4, 0.48 mg NaC1, 
7.6 g KCI, 0.096 g MgSO4,  11.6 g Trizma base (Sigma Chemical Co., St. Louis, Mo.), 0.096 
ml 1 M  CaCI2,  1.0 g NH4CI, 2.0 g glucose, and 20 ml of 5% casamino acids (23).  10 ~1 of TSB 
culture containing =  10  e E.  coli was  added to  10  ml  of Tris buffered,  minimal phosphate 
medium  containing  50  #Ci  of asP-labeled orthophosphate  (New  England  Nuclear,  Boston, 
Mass.). Bacterial growth was allowed to proceed in a shaking incubator for 16 h at 37°C at 400 
rpm.  Bacteria were harvested by centrifugation at  10,000  g  for  10  min  at 4°C  in a  Sorvall 
RC2B centrifuge (DuPont Instruments-Sorvall, DuPont Co., Newtown, Conn.). After washing 
three times with  phosphate-buffered saline and  two times with GHBS,  bacteria were resus- 
pended to a  concentration of 5  ×  10  s E.  coli/ml and standardized spectrophotometrically at 
650 nm where 5  ×  10  s bacteria/ml =  0.8 adsorbance units. Incorporation of asp was 37-40% 
of total, with the resulting E.  coli exhibiting a  specific activity of 300,000  cpm/10 v bacteria. 
Distribution ofa3P in the labeled E. coli was determined using the method of Roberts et al. (24). 
Approximately  83% of the radiolabel was incorporated into nucleic acids, 5% into phospholipids, 
and the remaining 12% into non-trichloroacetic precipitable material which includes lipopoly- 
saccharides. 
Deposition of Complement Proteins onto Bacteria.  Reaction mixtures of 400/L1 contained 200 #1 
of bacteria  (1  ×  109/ml)  in  GHBS,  200  pl  of either  C4-depleted  serum  or  the  isolated 
component mixture, and 0.5 pCi of radio-iodinated C3 or nP or C9. After periods of time at 
37°C, 40-#1 aliquots were withdrawn and specific binding determined after separation of cell 
bound  and  free  radioactive protein  as  described elsewhere  (25).  Controls  contained  heat- 
inactivated serum or heat-inactivated isolated component  mixture  (56°C,  30  min), bacteria 
and radiolabeled proteins. 
Assays of Bactericidal and Bacteriolytic Activity.  Total reaction mixtures of 45/tl which contained 
8  5  3at  .  ×  10  PE. coh, 25plGHBS,  O.15mMCaCI2,0.5mMMgC12,  andvarymgamountsofC4- 
depleted serum or isolated component mixture were incubated at 37°C. Controls included heat- 
inactivated  (56°C,  30  min)  C4,depleted  serum,  heat-inactivated  (56°C,  30  rain)  isolated 
component mixture and buffer. Effects on viability were determined by plating on agar. 5-#1 
samples of the reaction mixtures were diluted 20,O00-fold  and 50-/.tl aliquots applied to agar 872  BACTERICIDAL ACTIVITY OF THE  ALTERNATIVE COMPLEMENT  PATHWAY 
plates containing 3% TSB. Triplicate plates were incubated for 18 h at 37°C and the number 
of colonies determined. 
Bacteriolysis was determined as a  function of 33p release into the supernate.  30 p,l of the 
reaction mixture was layered onto a 300/~1 cushion of 20% sucrose dissolved in VB +÷ in a 400 
/zl polyethylene microfuge tube. Separation of cell associated and  released radioactivity was 
achieved  by centrifugation at  13,000  g  for  3  min  in  a  Beckman  microfuge  152  (Beckman 
Instruments,  Inc.,  Clinical Instrument  Div., Fullerton, Calif.). Tubes  were clamped with  a 
hemostat 5 mm above the bottom and the pelleted cells discarded by sectioning the tube at the 
lower edge of the hemostat with a razor blade. The tubes were inverted into 20-ml scintillation 
vials and the hemostat released. The sucrose solution which contained released 3ap was forced 
out the top of the tube by pressure exerted with a  12-ml syringe from the tube bottom. Total 
radioactivity was determined by addition of 30 #1 of reaction mixture and  300/tl of sucrose 
solution directly into a scintillation vial. Radioactivity ofaaP was assessed using a Beckman LS- 
230 liquid scintillation system (Beckman Instruments, Inc., Clinical Div.) employing a scintil- 
lation cocktail which consisted of 5% acetic acid, 8% H20, and 87% Scintiverse (Fisher Scientific 
Company, Pittsburgh, Pa.). 
Transmission Electron Microscopy.  Washed samples were prepared by negative staining with 
12 mM uranyl oxalate, pH 6.8, as described elsewhere (26). Electron microscopy was performed 
with a Hitachi  12 A electron microscope (Perkin-Elmer Co., Mountain View, Calif.) operated 
at 75 kV with a direct magnification of 50,000. 
Scanning Electron Microscopy.  Washed samples containing 2 ×  106 treated E. coli were applied 
to a  0.4-p~ nucleopore filter (Nuclepore Corp., Pleasanton, Calif.) which had been pretreated 
with  1%  poly-L-lysine (70,000-100,000  dalton  mol  wt,  Sigma  Chemical  Co.).  Filter-bound 
bacteria were fixed in a  modified Karnofsky fixative containing 0.72%  glutaraldehyde (EM 
grade),  1.02% paraformaldehyde  and  0.125  M  cacodylate  buffer,  pH  7.0. Samples  were 
dehydrated and dried in a Bomar SPC-900/EX critical point drier (The Bomar Co., Tacoma, 
Wash.)  using Freon  13  (Matheson  Co., Cucamonga,  Calif.) as the transition fluid. Electron 
microscopy was performed with a Hitachi 500-SEM at 25 kV at a 5-mm working distance. 
Light Scattering.  Reaction mixtures of 200/.tl contained  1.75  ×  107 E. coli K12 W1485, 50 
p,l GHBS and  150 #1 of either the isolated component mixture or heat inactivated (56°C,  30 
min) isolated components or buffer. Reactions were performed at 37°C in 400 p,1 microcuvettes 
in a Gilford 240 spectrophotometer equipped with a thermostatically controlled cuvette changer 
(Gilford Instrument Laboratories Inc., Oberlin, Ohio). Light scattering changes were measured 
as the change in adsorbance at 650 nm as a function of time. At the end of the reaction period, 
a  sample of bacteria was removed  from  each cuvette,  diluted, and  viability determined by 
plating. 
Results 
Activation  of the Alternative  Pathway by E.  coli  KI2  W1485 in  Absence  of Immunogtobu- 
lins.  The bacteria were incubated at 37°C for 30 rain with either isolated component 
mixture or C4-depleted serum.  400/tl of reaction mixture contained  2  ×  108 E.  coli 
and  one-half physiological concentrations  of either  isolated component  mixture  or 
C4-depleted  serum.  40-#1  samples  were  withdrawn  at  timed  intervals  and  after 
removal of unbound protein, specific uptake of radiolabeled C3b, properdin, and C9 
was quantitated.  Fig.  1 shows the time-course of uptake of the three proteins by the 
bacterial cells. After an  initial lag of 25  min,  C3b  and  properdin  deposition com- 
menced and reached a maximum at 20-25 min. At that time, the number of molecules 
bound  per  bacterium  was  35,000  for  C3b  and  12,000  for  properdin.  These  values 
represent  1% and 25% of C3 and properdin input, respectively. For technical reasons, 
C9 deposition was measured at  15-min intervals. Therefore, the time-course does not 
reveal an initial lag, but shows that in C4-depleted serum deposition is maximal only 
at 30 rain. A total of 40,000 C9 moleucles were bound per bacterium, which represents 
17% of input and is equivalent to ~  i0,000 C5b-9 dimers (27). These results show that 40 
30. 
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Fie.  l.  Comparable kinetics of activation by E. coli KI2 W1485 in the isolated component mixture 
and in C4-depleted human serum, as evidenced by quantitative measurements of C3b, properdin, 
and  C9  deposition.  Reactions  were  performed  as  described  in  Materials  and  Methods.  0,  C4- 
depleted serum; O, isolated component mixture. 
Fro.  2,  Loss of viability orE.  colt' KI2 W1485 by treatment with the isolated component system: 
Lack of lysozyme requirement. Reactions were performed as described in Methods. Loss of viability 
was determined by plating. The concentration of egg white lysozyme used was 10 #g/ml of isolated 
component mixture. 874  BACTERICIDAL ACTIVITY OF THE ALTERNATIVE COMPLEMENT  PATHWAY 
TABLE I 
Differentiation between Bactericidal and Bacteriolytic Activity of the Isolated Component Mixture 
Treatment  No. of colonies  3Sp release 
Buffer  217  ±  7  14.6 
I(SM  +  Lysozyme*  3  ±  l  62.6 
ICM  23 ±  5  19.3 
I(3M (56°C, 30 min) +  Lysozyme  284 ±  11  13.6 
C4-Depleted Serum  0  55.5 
C4-Depleted Serum (56°C, 30 min)  220 ±  18  6.9 
ICM, isolated component mixture. 
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FIG.  3.  Lysozyme requirement  for  the  lysis of E.  coli  K12  W1485  by  the  isolated  component 
mixture. Reaction  mixtures of 45 pl  contained  10 ~l  isolated component  mixture, 8  ×  10  s 33p_ 
labeled E. coh', GHBS, and concentrations of egg white lysozyme varying from 0.16 to  10 pg/ml of 
component mixture. Incubations were allowed to proceed at 37°(3 for 60 min, after which time lysis 
was assessed by measurement of~P release as described in Methods. Controls for each concentration 
of lysozyme involved utilization of heat inactivated (56°C, 30 min) isolated components. None of 
these controls effected asp release which was greater than the buffer control. 
this strain of E.  coli was capable of activating the cytolytic alternative pathway and 
that such activation can be achieved in the total absence of immunoglobulins. 
Differentiation  between Killing and Lysis of E.  coli K12  W1485 by the Isolated  Component 
Mixture.  The effects of activation of the component  mixture on the bacterial cells 
were measured by determining viability and release of intracellular SSp (lysis). Fig. 2 
and Table I show the following results:  (a) the isolated components, per se, killed the 
bacteria without causing specific Sap release; (b) killing and aSp release occurred when 
the bacteria were incubated  with  the component  mixture containing  lysozyme;  (c) 
heated  components plus  lysozyme caused  no  killing  and  no 3Zp  release,  indicating 
that  lysozyme alone was  insufficient  to induce  lysis;  (d)  C4-depleted  serum, which 
contains lysozyme, effected killing and lysis to an extent comparable to the isolated 
component mixture. 
Fig. 3 depicts the dependence of~aP release on the concentration of lysozyme in the 
isolated component mixture. The plateau of the dose-response curve is reached at 2.5- 
5 pg/ml, while 7 pg/ml correspond to the activity of lysozyme in human serum. That 
4% of 33p is released in absence of lysozyme may be related to the extraction of some 
cell wall phospholipids by the membrane attack complex (26, 28) or to the complement 
dependent  escape of low  molecular weight  phosphorus  compounds  from  the  peri- 
plasmic space (13). SCHREIBER  ET  AL. 
TABLE  II 
Control Experiments of the Bactericidal and Bacteriolytic Isolated Component System 
(Including Lysozyme) 
875 
Components deleted  No. of colonies  aap release* 
% 
None  0  47.4 
Lysozyme  1  I. 7 
Six alternative pathway proteins  79  0.0 
C5-C9  76  0.0 
C8, C9  76  4.O 
C9  8O  0.0 
Factor B  84  0.1 
All (buffer)  86  0.0 
* Corrected for spontaneous ~P release. 
T5 
50  ol: 
L 
~.  25 
to  2'o 
Serum or isolated Component Mixture I,II 
3'0 
FiG.  4.  Dose-dependent  lysis of E.  coli  KI2  W1485  by  the  I1  isolated  proteins of the cytolytic 
alternative pathway and lysozyme. Incubations at 37°C for 60 min were performed as described in 
Methods using the  isolated component mixture or C4-depleted  serum. Lysozyme concentrations 
used were 10/.tg egg white lysozyme/ml isolated component mixture. O, isolated component mixture 
plus lysozyme;/'-1, C4-depleted serum. 
The control experiments are listed in Table II. No killing and no lysis was observed 
when  the  reaction  mixture  lacked  the  six  alternative  pathway  proteins  or the  five 
membrane  attack  pathway  proteins,  or when  either  factor B, or C8 and  C9,  or C9 
were deleted. 
Quantitative Comparison of the Bacteriolytic Activity  of the Isolated  Component Mixture and 
C4-Depleted Serum.  Both the component mixture and the serum contained compara- 
ble  concentrations  of  the  respective  complement  proteins  and  lysozyme.  Fig.  4 
demonstrates  that  the  bacteriolytic  activity  of the  component  mixture  is  virtually 
identical to that of C4-depleted serum, 50% of maximal a3p release was obtained with 
4.0/xl and 3.6/~1  of the mixture or serum, respectively.  Similarly, the kinetics of lysis 
were comparable for both reaction mixtures, with lysis approaching completion after 
45 min at 37°C (Fig. 5). 
Because the function of the alternative  pathway is highly sensitive to dilution  (29, 
30),  we tested  the dependence of the  bacteriolytic activity on protein  concentration 
using the isolated component mixture.  Fig. 6 demonstrates  that at a  dilution of 1  : 11 
the activity was reduced to 50% and that at  1:16 it became insignificant. 
The Nonessential Role of Properdin in the Lysis orE. coli K12 W1485.  Because properdin 
was originally viewed as a  key component of the alternative  pathway (31), we tested 
its  requirement  for  lysis  of E.  colt KI2  W1485.  Fig.  7  shows  that  the  isolated 876  BACTERICIDAL ACTIVITY OF  THE  ALTERNATIVE COMPLEMENT  PATHWAY 
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F[o.  5.  Kinetics of alternative  pathway lysis  of E.  coli K12  W1485:  comparison of the  isolated 
component mixture and C4-depleted  human serum. Reaction mixtures of 446/d contained 2.2  × 
107 SaP-labeled  E.  coli, and 221  /~1 of either the isolated component mixture containing 4.5/Lg  egg 
white lysozyme or C4-depleted serum. Controls contained either heat-inactivated C4-depleted serum 
or heat-inactivated isolated component mixture or buffer. Reaction mixtures were brought to 37°C, 
and at designated times, 30-/~1 samples were removed and ZSp release determined. I'q, C4-depleted 
serum; O, isolated components +  lysozyme. 
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FIG. 6.  Effect  of dilution of the lysis of E. coli K12 W 1485 by the isolated component mixture and 
lysozyme.  Reaction  mixtures  contained  10  ~1  isolated  component  mixture,  100  ng  egg  white 
lysozyme, 8  ×  10  ~ 33P-labeled  E. coli and varying amounts of GHBS to yield the indicated dilutions. 
Incubations at  37"C  were performed  for 60  rain.  A  constant  percentage of the  volume of each 
reaction mixture was used to determine release  of intracellular 33p. Separate controls for nonspecific 
radiophosphorus release and total radioactivity were performed for each dilution. 
components lacking properdin are capable of generating bacteriolytic activity. There- 
fore,  properdin  cannot  be  considered  an  essential  component  in  this  system.  Its 
presence, in physiological amounts, however, led to an apparent threefold increase in 
bacteriolytic activity. 
Distinct Electron Microscopic Appearances of Killed and Lysed E. coli K12  W1485.  The 
results  presented  so  far  indicate  that  dependent  on  the  presence  or  absence  of 
lysozyme, the isolated component system effected either killing or lysis of the exposed 
bacteria.  Because killing was C9 dependent  and because adsorption of C9 results in 
formation of the membrane attack complex (C5b-9)z, the killed bacteria were exam- 
ined for the presence of the characteristic complement lesions by transmission electron 
microscopy and compared with lysed bacteria.  Fig. 8  demonstrates that  both killed 
and lysed bacteria exhibit comparable numbers of complement lesions which, in both 
cases,  are  of similar  size  and  appearance.  Both  preparations  also  showed  similar 
irregularities in surface structure which are most apparent along the edges of the cells SCHREIBER  ET  AL.  877 
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Flc.  7.  The enhancing, regulatory role of properdin for lysis of E. col: K 12 W 1485. Dose-dependent 
lysis of ~P-labeled E. col:" with the isolated component mixture either containing or lacking properdin 
were  performed  as  described  in  Methods.  Lysozme  concentrations used  were  10  #g  egg  white 
lysozyme/ml of isolated component mixture. Incubations were performed at 37°C for 60 min. 
Flc. 8.  Transmission  electron microscopy  of E.  col:" after treatment with the isolated component 
mixture lacking (B)  or containing (C)  lysozyme. Control (A) was treated with heat-inactivated 
isolated components and lysozyme.  Magnification: X 250,000. 
or cell  fragments. These structures  may be a  result  of the marked reorganization of 
surface phospholipid molecules known to be caused by the membrane attack complex 
(26). 
By scanning electron microscopy (Fig.  9)  the killed bacteria exhibited a  larger size 
than the controls. The size had increased approximately twofold and irregular surface 
protrusions became evident. In addition, the killed bacteria displayed sizable depres- 
sions of the  cell  wall.  These  marked  morphological changes correlated  with  killing 878  BACTERICIDAL ACTIVITY OF  THE  ALTERNATIVE COMPLEMENT  PATHWAY 
Fro.  9.  Scanning electron microscopy of alternative pathway killed or lysed  E.  coli K12 WI48b. 
Shown are E.  coli treated at  37°C for 60 min with buffer or the heat-inactivated (56°C,  30 rain) 
isolated  component mixture (A), the isolated component mixture (B, C), or the isolated  component 
mixture containing 10 #g/ml egg white lysozyme or C4-depleted serum (D). Concomitant analysis 
of viability and lysis revealed that compared to the control (A), samples  B and C were killed  and 
not lysed, whereas sample D was killed and lysed. Magnification:  ×  30,000. 
and were strictly dependent on C9. In contrast, the lysed ceils had lost any resemblance 
to their controls  and  had  assumed  a  random  polymorphic  appearance. 
The  apparent  swelling of the killed bacteria  compared  to controls  was  verified by 
light  scattering  measurements.  Fig.  10  shows  an  analysis  of the effect of the  isolated 
component  mixture on the adsorbance  at 650  nm  as a  function of time. After 60 rain SCHREIBER  ET  AL.  879 
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Flc.  10,  Increased  light  scattering  by  E.  coll" KI2  W1485  during  treatment  with  the  isolated 
component mixture. E. coli were incubated either with the isolated component mixture or with the 
heat-inactivated isolated component mixture (control) at 37°C as described in Methods. Adsorbance 
changes were followed at 650 nm. 
at  37°C  an increment of 65% was recorded.  At the end of these measurements, the 
viability of the treated bacteria was determined and found to be 30% of control. The 
data  are  consistent  with  the  conclusion  that  killing  increases  light  scattering  of a 
bacterial suspension approximately twofold. 
Discussion 
This  study  constitutes  the  first  demonstration  of the  generation  of bactericidal 
activity through  interaction  of the  11  isolated  plasma proteins which  comprise the 
cytolytic alternative pathway.  It also provides a  clear example that  the  alternative 
pathway  is  capable of expressing  bactericidal  activity  in  the  complete  absence  of 
immunoglobulins. The results are not at variance with observations made by others 
(8-11)  that suggest immunoglobulins are involved in the bactericidal function of the 
alternative pathway. Our preliminary results indicate that with certain strains of E. 
coli the addition of immunoglobulins to the isolated component system has a positive 
effect on killing. According to current views, the ability to differentiate between cells 
that can or cannot activate the alternative pathway, however, resides in C3b  (25).  It 
has been proposed that a low magnitude fluid phase C3 convertase, the initial enzyme 
of the alternative pathway, deposits C3b in a random fashion onto available surfaces 
of biological particles. Deposition of C3b occurs via its enzymatically exposed meta- 
stable binding site. Subsequently, bound C3b interacts with critical surface constitu- 
ents  of  activators  through  a  second,  discriminating  site.  This  interaction  allows 
uncontrolled  formation  of  the  activator-bound  C3  convertase, C3b,Bb  and  thus 
amplification.  When  the  discriminating  interaction  involving C3b  does  not  occur, 
such as on nonactivating particles, C3b is cleaved and inactivated by fllH and C3b 
inactivator and formation of the C3 convertase is prevented. 
Activator-bound C3 convertase catalyzes the binding of many C3b molecules and 880  BACTERICIDAL ACTIVITY  OF  THE  ALTERNATIVE COMPLEMENT  PATHWAY 
the  formation  of multiple  C3-convertase complexes.  As  a  result,  C5  convertase  is 
formed, properdin is recruited as a stabilizer of the enzyme, and membrane attack is 
initiated. Although properdin is the protein that originally revealed the existence of 
the alternative pathway and although it was thought to be the key component of the 
pathway (31), the results presented here shows that it fulfills no essential role in the 
particular bactericidal or bacteriolytic reaction examined in this study. This obser- 
vation is in agreement with previous work utilizing different systems which assigned 
to properdin the function of an enhancing regulator of the alternative pathway (22, 
25).  That  Pillemer et  al.  (31)  considered properdin an  essential  component of the 
system may be explained in part by its enhancing activity which, as shown with the 
isolated component mixture, is most apparent at low component concentrations (Fig. 
7).  Although  properdin  appears  to  have  only  a  minor  effect on  the  bactericidal 
reaction, it does have a marked effect on C3b deposition which varies with the strain 
of bacteria tested as preliminary results have shown. In this manner properdin may 
influence the fate of susceptible bacteria in vivo. 
To confer on the bactericidal alternative pathway bacteriolytic activity, the addition 
of lysozyme  to  the  component  mixture  was  necessary.  The  electron  microscopic 
analyses showed that in absence of lysozyme, the membrane attack complex clearly 
formed within  the outer lipid  bilayer:  typical complement membrane lesions were 
observed which have been shown to constitute the C5b-9 dimer (27).  These analyses 
also revealed additional changes, namely an uneven structure of the cell surface which 
is similar to that of membrane attack complex modified liposomes (26) and which has 
been  attributed  to  the  unusual  phospholipid  binding  capacity  of  the  complex. 
Concomitantly, the unlysed bacterium increases the surface area of its outer membrane 
approximately twofold. In spite of these drastic changes, no efflux of 3aP-containing 
cytoplasmic constituents  occurred. These  same  changes  of the  outer  phospholipid 
membrane probably afford lysozyme access to the  underlying peptidoglycan layer, 
enzymatic degradation of which eventuates in lysis. 
Although our results shows that E. coli K12 W1485 can be killed by the 11 cytolytic 
alternative pathway proteins, we do not wish to imply that susceptibility to killing by 
these proteins is a general property of gram-negative bacteria. Future work will have 
to determine the extent to which this property is shared by other strains. Even though 
certain strains may resist killing by the membrane attack complex, they may allow 
activation of the  alternative  pathway  and  opsonization by C3b  and  thus  become 
susceptible to phagocytosis.  It  is  conceivable on  the  basis  of kinetic considerations 
that in the presence of phagocytic cells, i.e., polymorphonuclear leukocytes, ingestion 
precedes killing and lysis in the fluid phase. Work is underway to determine the fate 
of susceptible bacteria in the isolated component system into which phagocytic cells 
have been introduced. 
Summary 
Exposure of E. coli K 12 W 1485 to the cytolytic alternative pathway assembled from 
the  11  isolated pathway proteins resulted in killing of the bacteria, as evidenced by 
loss  of viability.  Lysis of the  bacteria  required  introduction  of lysozyme into  the 
reaction mixture. The time-course and dose dependency of bacteriolysis in the isolated 
system were identical to those in C4-depleted serum. The bacteriolytic activity of the 
pathway was  highly dependent  on  the concentration of the  pathway proteins and SCHREIBER ET AL.  881 
became insignificant  at  1:16 physiological concentration.  Electron  microscopic visu- 
alization  of killed  and  of lysed bacteria  revealed  numerous complement  membrane 
lesions  and  partial  disintegration  of the  outer  phospholipid  membrane.  Scanning 
electron  microscopy showed  that  killed  bacteria  were  enlarged,  partially  collapsed 
and  exhibited  irregular  surface  protrusions.  Lysed  bacteria  were  fragmented  and 
appeared  polymorphic.  This  study  demonstrates  that  the  alternative  pathway,  in 
absence of immunoglobulins, has the potential of eradicating gram-negative bacteria. 
The authors are grateful to M. Brothers, B. Curry, K. Pangburn, and L. Wood for essential 
technical  assistance,  D.  Dipietro  performing scanning electron  microscopy, and  Doctors M. 
Pangburn,  A.  Esser,  and  G.  Biesecker  of this  laboratory  for contributing  to  the  supply  of 
isolated proteins. 
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